TP53 and cancer: Yet, we report here the failure to detect in vivo-primed p53-specific CD8+ T cell responses in cancer patients with spontaneous antibodies to p53 as well as in p53-seronegative patients and in healthy donors using our single in vitro sensitization protocol.